Canaccord


Canaccord Cheers Mast Therapeutics Inc (MSTX) In Light Of Strategic Merger With Savara

Mast Therapeutics Inc (NYSEMKT:MSTX) and privately held pharmaceutical firm Savara Inc. have announced the intent to merge to advance a novel pipeline of …

Canaccord Upbeat on Pandora Media Inc (P) on Back of Guidance Beat

Pandora Media Inc (NYSE:P) shares are climbing almost 9% today in pre-market trading after the music streaming firm pre-announced an outclass of its previous …

Why This Top Analyst Downgraded Nokia Corp (ADR) (NOK) Shares

Canaccord top analyst Michael Walkley has gone from bullish to sidelined on Nokia Corp (ADR) (NYSE:NOK) amid a short-term he sees rife with …

Valeant Pharmaceuticals Intl Inc Takes First Steps To Address Leverage: Canaccord

Canaccord analyst Neil Maruoka came out today with a few thoughts on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), following the news that the drug maker will sell …

Canaccord Cuts Price Tag on AEterna Zentaris Inc. (USA) (AEZS) Following Doomed Macrilen Phase 3 Failure; Shares Fall 8%

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are sinking 8% after the firm announced what Canaccord analyst Neil Maruoka deems “another disappointment for Macrilen,” …

This Top Analyst Bullish on Top Image Systems Ltd. (TISA); Shares Rise 22%

Top Image Systems Ltd. (NASDAQ:TISA) shares are escalating a solid 22% after the company announced this morning that its management restructuring has attained …

Canaccord Confident on Synergy Pharmaceuticals Inc (SGYP) Following Competitor Phase 3 Linzess CIC Trials Three-Day Treatment Break

Canaccord analyst John Newman is out today with a favorable research report on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) after the firm’s competition, Phase 3 …

Canaccord Analyst Recommends Investors to Stay on the Sidelines on Endologix, Inc. (ELGX); Shares Dive 27%

Endologix, Inc. (NASDAQ:ELGX) shares plunged almost 27% today after today’s announcement that the medical-device maker has placed AFX/AFX2 endografts on a temporary shipping …

Here’s Why Canaccord Sings the Praises of Synergy Pharmaceuticals Inc (SGYP); Shares Rise 5%

After market-close yesterday, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) released positive second Phase 3 results for plecanatide, the firm’s pipeline daily pill designed to treat …

Canaccord Assumes a Buy on Aerie Pharmaceuticals Inc (AERI)

Dewey Steadman at research firm Canaccord has come out with a bullish call on shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI). The analyst assumed …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts